inkmune
·Code: INB-16
inkmune: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Inmune Bio, Inc. (INMB) | Phase 1 |
Clinical Trials (1)
A Phase I Open-Label Dose Escalation Study Of Intravenous INKmune In Patients With Myelodysplastic Syndrome With Excess Blasts (MDS-EB-1/2 - MDS-CMML 1/2) Or Acute Myeloid Leukaemia (AML)
Frequently asked questions
Who is developing inkmune?
inkmune is being developed by Inmune Bio, Inc..
How many clinical trials involve inkmune?
BioSniper tracks 1 clinical trial involving inkmune.
Get deeper analysis on inkmune
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis